Verasonics Celebrates 25 Years of Empowering Ultrasound Innovation

KIRKLAND, Wash.–(BUSINESS WIRE)–#HealthcareInnovationVerasonics, Inc., the world’s leading provider of advanced ultrasound platforms for research and development, announced today the celebration of its 25th anniversary. Marking a quarter century of innovation, collaboration, and impact, this milestone highlights Verasonics’ longstanding commitment to empowering researchers, engineers, and commercial partners around the world with flexible, high-performance ultrasound technologies.

Verasonics 25th Anniversary logo
Verasonics 25th Anniversary logo
Verasonics Research Ultrasound
Verasonics Research Ultrasound

“From the beginning, our goal has been to give innovators the freedom to explore what’s possible with ultrasound,” said Jon K. Daigle, CEO of Verasonics. “Our 25th anniversary is a celebration of the researchers, engineers, and partners who have pushed and expanded the boundaries of ultrasound innovation.”

Founded in 2001, Verasonics introduced a new paradigm in ultrasound by replacing hardware-based beamforming with a highly programmable software-based ultrasound platform. This approach provided researchers with direct control over system parameters, access to real-time raw channel data, and the ability to leverage rapid advances in computing power, unlocking new possibilities for experimentation, rapid prototyping, and commercialization. This vision has helped redefine ultrasound innovation worldwide.

Today, Verasonics systems are trusted by research and development teams in academia, commercial and government institutions around the world and have supported thousands of scientific publications across biomedical imaging, focused ultrasound therapy, photoacoustics, and nondestructive testing (NDT). Through its advanced, programmable ultrasound platforms and close collaboration with the global ultrasound community, Verasonics continues to help drive innovation across a wide range of applications.

As Verasonics celebrates 25 years of empowering ultrasound innovation, the company remains focused on the opportunities ahead. With advancements accelerating across imaging, therapy, and interdisciplinary applications, Verasonics will continue to equip customers with the powerful, flexible tools they need to shape what comes next. Verasonics thanks its customers and partners for being an essential part of this journey and looks forward to empowering the next generation of ultrasound discoveries and innovations.

About Verasonics, Inc.

Headquartered in Kirkland, Washington, USA, Verasonics is a privately held company founded in 2001. Verasonics, the leader in research ultrasound, empowers ultrasound innovation worldwide by providing flexible ultrasound platforms for research, development, and commercialization. Verasonics solutions are used across biomedical ultrasound, materials science, earth sciences, and acoustics to help accelerate innovation from concept to market. Verasonics also licenses its technology to companies for use in their commercial products.

Learn more by visiting the Verasonics website or following us on LinkedIn and X.

Contacts

Media Contact:
Verasonics, Inc.

James Schada

T: 425-439-7235

E: [email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.